Patents by Inventor Daniela Cocconi

Daniela Cocconi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
    Publication number: 20110262543
    Abstract: Carrier particles for dry powder formulations for inhalation having reduced electrostatic charges are prepared.
    Type: Application
    Filed: April 21, 2011
    Publication date: October 27, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela Cocconi, Rossella Musa
  • PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
    Publication number: 20110262547
    Abstract: Carrier particles in which at least 60% of the surface is coated with magnesium stearate are useful for preparing dry powder formulations for inhalation.
    Type: Application
    Filed: April 1, 2011
    Publication date: October 27, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Alain Chamayou, Laurence Galet
  • PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE HAVING IMPROVED ADHESION PROPERTIES FOR POWDER FORMULATIONS FOR INHALATION
    Publication number: 20110097409
    Abstract: Powder particles comprising a pharmaceutically acceptable salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone (carmoterol) having a specific properties exhibit improved adhesion properties for dry powder formulations for inhalation. Such particles are useful for formulations in the form of powders for inhalation and the treatment of certain conditions and diseases.
    Type: Application
    Filed: November 25, 2009
    Publication date: April 28, 2011
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Francesca Buttini, Paolo Colombo, Chiara Parlati, Daniela Cocconi, Rossella Musa
  • INHALATION PARTICLES COMPRISING A SALT OF 8-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO] ETHYL]-2(1H)-QUINOLINONE AND A CORTICOSTEROID
    Publication number: 20100269825
    Abstract: Crystalline particles wherein each particle comprises a combination of a pharmaceutically acceptable salt of 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone (carmoterol), and a corticosteroid in a pre-determined and constant ratio are effective for the prevention and treatment of inflammatory or obstructive airways diseases.
    Type: Application
    Filed: February 25, 2010
    Publication date: October 28, 2010
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Daniela COCCONI, Rossella MUSA, Gaetano BRAMBILLA, Dipesh PARIKH, Graham RUECROFT
  • MICRONIZED PARTICLES OF LOW-DOSAGE STRENGTH ACTIVE AGENTS FOR POWDER FORMULATIONS FOR INHALATION
    Publication number: 20100055192
    Abstract: Micronized particles of a low-dosage strength active ingredient, to be used in dry powder formulations for inhalation, with particular properties can easily and homogenously disperse in a dry powder formulation to be administered by means of a dry powder inhaler device.
    Type: Application
    Filed: July 9, 2009
    Publication date: March 4, 2010
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Rossella Musa, Daniela Cocconi, Silvia Catinella
  • DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG
    Publication number: 20090192187
    Abstract: Pharmaceutical formulation in the form of inhalable dry powder comprising particles of a pharmaceutically acceptable salt of 3-[[[(3-fluorophenyl)[(3,4,5-trifluoro phenyl)methyl]amino]carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo [2.2.2]octane as active ingredient, and particles of a carrier made of a physiologically acceptable pharmacologically-inert material are effective for the prevention and/or treatment of a respiratory disease such as asthma and COPD.
    Type: Application
    Filed: December 24, 2008
    Publication date: July 30, 2009
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Gaetano BRAMBILLA, Rossella Musa, Daniela Cocconi
  • Pharmaceutical Formulations For Dry Powder Inhalers Comprising A Low-Dosage Strength Active Ingredient
    Publication number: 20070202053
    Abstract: The invention provides a formulation to be administered as dry powder for inhalation suitable for efficacious delivery of low-dosage strength active ingredients to the low respiratory tract of patient. In particular, the invention provides a formulation comprising microparticles constituted of microparticles of a low-dosage strength active ingredient and microparticles of an excipient wherein the MMD of the microparticles is comprised between 2 and 15 micron, at least 10% of the microparticles has a mass diameter (MD) higher than 0.5 micron, and the process of preparation thereof.
    Type: Application
    Filed: March 16, 2005
    Publication date: August 30, 2007
    Applicant: Chiesi Farmaceutici S.p.A.
    Inventors: Roberto Bilzi, Angela Armanni, Roberto Rastelli, Daniela Cocconi, Rosella Musa